TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026
Three Months of Weekly Rifapentine and Isoniazid Versus Four Months of Daily Rifampicin for Tuberculosis Infection: A Randomized Controlled Trial.
Vicky W L Chang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.